New York Heart Association

Also found in: Acronyms.

New York Heart Association



The professional society that promulgated four classes of heart failure. Class 1: is asymptomatic but there is risk because of hypertension with evidence of organ stress; Class 2: is mildly symptomatic during significant exertion; Class 3: is moderately symptomatic during light exertion; Class 4: the patient is unable to leave the room or bed without severe shortness of breath.
References in periodicals archive ?
Patients were eligible if they had heart failure with New York Heart Association class III or IV plus chronic kidney disease, and had recently been hospitalized for decompensation associated with fluid overload.
In the study, before, 30 and 90 days after the procedure, patients were assessed for the severity of their heart failure (stage 1-4), based on standard New York Heart Association criteria.
A majority of patients experienced dramatic improvement in symptoms through two years (87 percent improved to New York Heart Association class I or class II).
The pioglitazone label has a boxed warning stating that treatment with TZDs, including pioglitazone, can cause or exacerbate heart failure, and that patients on treatment with pioglitazone should be monitored closely for heart failure; it is contraindicated in patients with New York Heart Association (NYHA) III or IV heart failure.
New York Heart Association (NYHA) functional class improved in the active treatment group at 1 week (p < 0.
New York Heart Association Class IV end-stage left ventricular failure for at least 90 days with a life expectance of less than 2 years.
6 million New York Heart Association (NYHA) class III chronic heart failure patients by improving patient hemodynamics and potentially improving quality of life.
The study also showed significant improvements in quality of life at one year which were sustained through four years, with 74 percent of patients improving at least one New York Heart Association (NYHA) functional class from baseline to four years.
2]), exercise duration, and New York Heart Association functional class among patients taking about 5 g of omega-3 polyunsaturated fatty acids (PUFAs) daily for 1 month followed by another 11 months of 2-g daily doses (J.
The remaining 9 patients showed significant improvement in mean left ventricular ejection fraction and in Modified New York Heart Association functional class, which enabled them to be removed from the heart transplant waiting list.
Additionally, as in PROTECT II, there was a significant improvement of the functional heart failure status by one or more New York Heart Association (NYHA) classes.
Eligible patients had either New York Heart Association class III heart failure and a left ventricular ejection fraction of 45% or less, or class II heart failure and an ejection fraction of 40% or less.

Full browser ?